Skip to main content

Year of the Fetus

2012 saw the birth of a handful of non-invasive genetic prenatal tests, but the young industry faces growing pains as legal and ethical questions loom. 

Written byBeth Marie Mole
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00

Flickr, abbybatchelderIn the not-so-distant past, testing an unborn baby for Down syndrome and other severe genetic disorders required a procedure with a long, gruesome needle and an unnerving risk of miscarriage. But this year, doctors and pregnant women around the country welcomed a new option: a painless genetic screen performed on a sample of the mother-to-be’s blood.

Advances in DNA sequencing have given doctors the power to probe the small fraction of fetal DNA coursing through a pregnant woman’s veins. Approximately 3 to 10 percent of the cell-free DNA in a mother’s blood belongs to her baby, and these fetal blueprints are enough to determine if the baby has the wrong number of certain chromosomes—the cause of some inherited diseases, including Down syndrome. And, instead of an invasive procedure at 15 to 20 weeks of pregnancy, doctors can conduct a genetic screen of the mother’s blood as early as week 10 with a standard blood draw.

Though the technology behind non-invasive prenatal genetic testing officially debuted in October of 2011, this year saw the birth of the first generation of options, with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi
Advancing Research With Humanized Mouse Models

Advancing Research with Next-Generation Humanized Mouse Models

bioxcell
3d illustration showing amyloid plaques in Alzheimer's disease

Best Practices for Blood-Based Amyloid Pathology Testing

fujirebio logo
Optimizing Critical Steps in T-Cell Engineering

Optimizing Critical Steps in T-Cell Engineering

Fujifilm

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen